Guttman-McCabe Christopher sold ATEX
June 15, 2026 · Form 4 insider transaction
Guttman-McCabe Christopher sold 5,030 shares of Anterix Inc. at $79.53 per share, a transaction worth $400.0K. The trade was recorded as open-market sale and disclosed on an SEC Form 4, filed 60 days after the transaction.
Footnotes
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $79.085 to $80.035, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of securities sold at each separate price within the ranges set forth in this footnote to this Form 4.; This Form 4/A amends the Form 4 filed by the reporting person on June 17, 2026 (the "Original Form 4"), which due to a clerical error inadvertently reported the incorrect number of securities sold in column 4 of Table I and the amount of shares beneficially owned in column 5 of Table I. This Form 4/A is being filed solely to correct the number of securities reported in column 4 and column 5 of Table II to reflect that an additional 31,415 shares were sold. No other amendments or changes have been made to the Original Form 4, except as reported in the Form 4/A filed by the Reporting Person on July 10, 2026.